Cyclical neutropenia and other periodic hematological disorders: a review of mechanisms and mathematical models.
Although all blood cells are derived from hematopoietic stem cells, the regulation of this production system is only partially understood. Negative feedback control mediated by erythropoietin and thrombopoietin regulates erythrocyte and platelet production, respectively, but the regulation of leukocyte levels is less well understood. The local regulatory mechanisms within the hematopoietic stem cells are also not well characterized at this point. Because of their dynamic character, cyclical neutropenia and other periodic hematological disorders offer a rare opportunity to more fully understand the nature of these regulatory processes. We review the salient clinical and laboratory features of cyclical neutropenia (and the less common disorders periodic chronic myelogenous leukemia, periodic auto-immune hemolytic anemia, polycythemia vera, aplastic anemia, and cyclical thrombocytopenia) and the insight into these diseases afforded by mathematical modeling. We argue that the available evidence indicates that the locus of the defect in most of these dynamic diseases is at the stem cell level (auto-immune hemolytic anemia and cyclical thrombocytopenia seem to be the exceptions). Abnormal responses to growth factors or accelerated cell loss through apoptosis may play an important role in the genesis of these disorders.
Departments of Physiology, Physics, and Mathematics, Center for Nonlinear Dynamics in Physiology and Medicine, McGill University, Montreal, Quebec, Canada.
C
C
Haurie
D C
DC
Dale
M C
MC
Mackey
D000741:Anemia, Aplastic / Q000503:physiopathology; D000744:Anemia, Hemolytic, Autoimmune / Q000503:physiopathology; D000818:Animals; D001772:Blood Cell Count; D004283:Dog Diseases / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology; D004285:Dogs; D005246:Feedback; D006402:Hematologic Diseases / Q000503:physiopathology*; D016298:Hematopoietic Cell Growth Factors / Q000502:physiology / Q000627:therapeutic use; D006412:Hematopoietic Stem Cells / Q000473:pathology; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000503:physiopathology; D008954:Models, Biological; D009503:Neutropenia / Q000188:drug therapy / Q000235:genetics / Q000503:physiopathology* / Q000662:veterinary; D010507:Periodicity; D011087:Polycythemia Vera / Q000503:physiopathology; D013921:Thrombocytopenia / Q000503:physiopathology
D016298:Hematopoietic Cell Growth Factors